Roche reports solid results in 2020 On 4. Februar 2021 Filed under MESSE/FAIR Pharmaceuticals Division sales decline 2%; continued strong sales growth of newly launched medicines (+32% 2, including Tecentriq, Hemlibra, Ocrevus, Perjeta and Kadcyla) largely offsets the impact o … (Orginal – Story lesen…)